WallStSmart
SHC

Sotera Health Co

NASDAQ: SHC · HEALTHCARE · DIAGNOSTICS & RESEARCH

$15.43
+0.32% today

Updated 2026-06-05

Market cap
$4.62B
P/E ratio
39.49
P/S ratio
3.88x
EPS (TTM)
$0.41
Dividend yield
52W range
$11 – $20
Volume
3.4M

Sotera Health Co (SHC) Stock Valuation Analysis

Fair value estimate, historical valuation range, and quality signals for SHC.

WallStSmart Verdict
Fairly
Valued

Valuation reasonably reflects current fundamentals. Limited margin of safety at these levels.

Smart Value Score: 68 / 100
P/E (TTM)
39.5x
vs 5Y median of 57.7x
PEG
1.68
Fair range
Margin of Safety
DCF limited for this profile
EV / EBITDA
0.0x

SHC historical valuation range

Where current P/E sits in SHC's own 5Y range.

NOW
15.5x
5Y Low
43.9x
25th
57.7x
Median
74.8x
75th
145.8x
5Y High
SHC is trading cheaper than 78% of the last 5Y.
22th percentile · Historically cheap

SHC intrinsic value (DCF)

DCF-based fair value estimate vs current market price.

DCF has limited applicability for SHC

Standard discounted cash flow models produce unreliable output for unprofitable or near-breakeven companies. Revenue-based multiples such as P/S and EV/Sales, combined with the historical valuation position above, give a more reliable read for this stock.

Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.

SHC valuation signals

Quick-read green flags, caution flags, and risks based on current metrics.

!
PEG in fair range
PEG of 1.68 suggests price reflects growth fairly. Neither a bargain nor overpriced.
P/E near 5Y low
Current P/E sits in the 22th percentile of its 5Y range. Historically cheap relative to its own history.
!
DCF limited applicability
Company profile produces unstable DCF output. Lean on P/S, EV/Sales, and historical valuation position instead of intrinsic value for this stock.

P/E Ratio — History

Current: 39.49x

P/S Ratio — History

Current: 3.88x

Is SHC overvalued in 2026?

Sotera Health Co (SHC) currently trades at $15.43 per share with a market capitalization of $4,616,854,000.00. Based on our multi-factor framework, the stock trades at a fair valuation with a Smart Value Score of 68/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.

The stock trades at a P/E ratio of 39.5x, below its 5-year median of 57.7x. The PEG ratio of 1.68 points to a price that reasonably reflects expected earnings growth.

Looking at its own history, SHC is currently trading cheaper than 78% of the last 5Y on P/E. This places it in the 22th percentile of its historical range, a level that has historically coincided with attractive entry points.

A standard DCF model does not produce reliable output for SHC under current conditions. For unprofitable or near-breakeven companies, revenue-based multiples such as EV/Sales and historical P/S percentile are more informative than intrinsic value calculations.

The Piotroski F-Score of 4/9 puts financial quality in a middling range, neither a standout strength nor an obvious red flag.

Bottom line: SHC trades at a fair valuation on our framework, with a Smart Value Score of 68/100. The valuation is defensible but offers no obvious bargain. Patience or a better entry price may reward disciplined buyers.

Frequently asked questions

Is SHC overvalued?

SHC scores 68/100 on our Smart Value Score (Grade B), a mixed overall profile. A standard DCF is unreliable here given the profitability profile, so valuation leans on revenue-based measures like EV/Sales and the P/S percentile below.

What is SHC's fair value?

A standard DCF is unreliable for SHC given its current profitability profile. Revenue-based approaches like EV/Sales or the historical P/S percentile are more informative for this stock.

What P/E ratio does SHC trade at?

SHC trades at a P/E of 39.5x on trailing twelve-month earnings, against a 5-year median of 57.7x. P/E is what you pay per dollar of profit, and sitting below its own median means the stock is cheaper than usual relative to its earnings.

Is SHC a buy based on valuation?

Our Smart Value rating for SHC is Buy, from a Smart Value Score of 68/100 that blends growth, quality, and valuation. The profile is balanced and best suited to investors who already have a thesis. This is research to inform your decision, not personalized financial advice.

How does SHC's valuation compare to its history?

On P/E, SHC sits in the 22nd percentile of its own 5Y range, historically cheap relative to where it has traded. A low percentile means today's multiple is near the bottom of its historical band.

What is SHC's Smart Value Score?

SHC's Smart Value Score is 68/100. It is a proprietary WallStSmart metric blending growth quality, financial health, and valuation into a single 0-100 read, and scores above 75 are rare, signaling strong multi-factor alignment.